Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
64.40
-0.80 (-1.23%)
At close: Aug 22, 2025, 4:00 PM
64.40
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:00 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.11 billion as of August 22, 2025. Its market cap has increased by 53.95% in one year.
Market Cap
2.11B
Enterprise Value
1.97B
1-Year Change
53.95%
Ranking
Category
Stock Price
$64.40
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.11B, an increase of 1,362.57%. That is a compound annual growth rate of 124.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 2.14B | 9.87% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |